A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)

Trial Profile

A Phase 1 Open-Label, Single-Center Study to Evaluate the Safety and Tolerability of Topical Ocular PAN-90806 in Patients With Proliferative Diabetic Retinopathy (PDR)

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Oct 2016

At a glance

  • Drugs PAN 90806 (Primary)
  • Indications Diabetic retinopathy
  • Focus Adverse reactions
  • Sponsors PanOptica
  • Most Recent Events

    • 27 Sep 2016 Status changed from active, no longer recruiting to completed.
    • 24 Mar 2016 Planned End Date changed from 1 Apr 2016 to 1 Jul 2016 as reported by ClinicalTrials.gov.
    • 24 Mar 2016 Planned primary completion date changed from 1 Mar 2016 to 1 May 2016 as reported ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top